Troponin testing: an audit in three metropolitan hospitals

Richard X Davey

Melbourne Health Shared Pathology Service, Western Hospital, Footscray, VIC 3011.

Correspondence: Richard.Davey@wh.org.au

1. Chiu A, Chan W-K, Cheng S-H, et al. Troponin-I, myoglobin, and mass concentration of creatine kinase-MB in acute myocardial infarction. Q J Med 1999; 92: 711-718.
2. Balk EM, Ioannidis JP, Salem D, et al. Accuracy of biomarkers to diagnose acute cardiac ischemia in the emergency department: a meta-analysis. Ann Emerg Med 2001; 37: 478-494.
3. Wu AHB, Apple FS, Warshaw MM, editors. Recommendations for the use of cardiac markers in coronary artery disease. Washington: AACC Press, 1999.
4. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined — a consensus document of the joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. JACC 2000; 36: 959-969.
5. Boufous S, Kelleher PW, Pain CH, et al. Impact of a chest-pain guideline on clinical decision-making. Med J Aust 2003; 178: 375-380. <eMJA full text>
6. Davey RX. Troponin testing: an audit in three metropolitan hospitals. Med J Aust 2003; 179: 81-83. <eMJA full text>

Online responses are no longer available. Please refer to our instructions for authors page for more information.